hero background

ChondroFiller® at the Liquid Cartilage

Injectable, Structural Regenerative Implant for Cartilage Care

Protect • Repair • Regenerate

← Back Home
ChondroFiller Advances Minimally Invasive Cartilage Repair in Orthopaedics

ChondroFiller Advances Minimally Invasive Cartilage Repair in Orthopaedics

Introduction

Cartilage injuries are a common source of joint pain and stiffness, often affecting movement and day-to-day activities. Since cartilage has no blood supply, it struggles to heal naturally, making effective treatment essential to stopping further damage and improving quality of life. Luckily, advances in orthopaedics have brought minimally invasive treatments to the fore, offering patients gentler alternatives to traditional surgery. One promising innovation is ChondroFiller, a technique designed to repair cartilage without the need for large incisions or extensive surgery. In this article, we’ll explain why ChondroFiller is considered minimally invasive and explore how it differs from conventional treatments, along with the benefits it offers patients.

What Is ChondroFiller? A Simple Guide

ChondroFiller is a specialised treatment aimed at repairing small to medium cartilage defects. It works by injecting a liquid collagen matrix directly into the damaged cartilage area. This cell-free collagen acts like a scaffold, encouraging the body’s own cartilage cells to grow and repair the defect. The procedure is usually done via keyhole surgery, requiring only a tiny incision. This means less disruption to surrounding tissues and a gentler overall experience for the patient. To put it simply, ChondroFiller “constitutes a bi-phasic structure, where the 60% nonfibrillar hydrogel proportion dominates the mechanical response” — in other words, its unique makeup helps it provide the right support to encourage healing (Weizel et al., 2020).

How Does ChondroFiller Differ from Traditional Cartilage Repair Methods?

Traditional cartilage repair often involves open surgery with larger cuts to access the joint. This can lead to more tissue damage, longer stays in hospital, and extended recovery times. In contrast, ChondroFiller uses a minimally invasive keyhole approach via a small incision. This reduces trauma and speeds up healing, so patients typically experience less pain and get back to their routines sooner. The material itself is well studied — for example, “ChondroFillerliquid shows the most pronounced viscous effects” compared to similar products, meaning it behaves flexibly within the joint (Weizel et al., 2020). Clinical evidence also supports these benefits: “The liquid AMIC is a safe technique that shows good clinical and radiological outcomes in a 2-year follow-up” for hip cartilage defects treated arthroscopically (De Lucas Villarrubi et al., 2021). What’s more, surgeons have developed clever techniques to improve the delivery of ChondroFiller. One such method is using a curette combined with a needle for precise placement during arthroscopy — described as “a simple, inexpensive, and reproducible technique” to treat hip cartilage defects in just one step (Perez-Carro et al., 2021). While bone cement remains an option in specific cases such as fractures or cancer, leading UK societies recommend uncemented implants in many situations. This fits with our clinic’s positive outcomes using uncemented options, reflecting modern best practice.

Free non-medical discussion

Not sure what to do next?

Book a Discovery Call

Information only · No medical advice or diagnosis.

Patient Benefits – Why Minimally Invasive Matters

Minimally invasive treatments like ChondroFiller offer several patient-focused advantages. Smaller incisions lead to less tissue damage and reduced post-operative pain. This lowers the chance of complications such as infection. Patients usually find these procedures less daunting, with smaller scars and a quicker return to everyday life and work. From a technical standpoint, “the mechanical behaviour of cartilage tissue plays a crucial role in physiological mechanotransduction processes,” highlighting the importance of using repair materials that behave like natural cartilage (Weizel et al., 2020). Patient outcomes back up these benefits: “95% of the patients met the minimal clinically important difference (MCID)… and 100% scored above the patient acceptable symptomatic state (PASS),” with satisfaction rates around 87% (De Lucas Villarrubi et al., 2021). The surgical approach is praised as “a simple, inexpensive, and reproducible technique” that delivers biologic and injectable materials efficiently during hip arthroscopy (Perez-Carro et al., 2021). Overall, minimally invasive cartilage repair balances safety, effectiveness, and patient comfort.

Expertise and Support – The Role of Professor Paul Lee and MSK Doctors

Professor Paul Lee is a highly regarded expert in cartilage repair, serving as Regional Surgical Ambassador and Advisor to the Royal College of Surgeons of Edinburgh. His extensive experience guides MSK Doctors in providing safe, evidence-based orthopaedic care. MSK Doctors pride themselves on blending cutting-edge innovation with strong clinical governance, ensuring patients receive thorough assessments and tailored treatment plans. Both Professor Lee and the team champion minimally invasive options like ChondroFiller, focusing on precise, well-researched therapies that improve patient wellbeing while setting realistic expectations.

Conclusion

ChondroFiller offers a promising, minimally invasive solution for cartilage repair. By using a small incision and a specialised collagen matrix, it reduces tissue trauma and accelerates recovery compared to traditional open surgery. Patients with cartilage damage should consult experienced orthopaedic specialists such as Professor Paul Lee and the MSK Doctors team to explore personalised treatment options. With ongoing advances, minimally invasive techniques like ChondroFiller are set to play a growing role in musculoskeletal care—helping patients regain mobility and improve their quality of life.

References

  • Weizel, A., Distler, T., Schneidereit, D., & Friedrich, O. (2020). Complex mechanical behavior of human articular cartilage and hydrogels for cartilage repair. Acta Biomaterialia, 122, 255–265. https://doi.org/10.1016/j.actbio.2020.10.025
  • De Lucas Villarrubi, J. C., Méndez Alonso, M. Á., Sanz Pérez, M. I., Trell Lesmes, F., & Panadero Tapia, A. (2021). Acellular Matrix-Induced Chondrogenesis Technique Improves the Results of Chondral Lesions Associated With Femoroacetabular Impingement. Arthroscopy: The Journal of Arthroscopic & Related Surgery, 37(12), 3579-3588. https://doi.org/10.1016/j.arthro.2021.08.022
  • Perez-Carro, L., Mendoza Alejo, P. R., Gutierrez Castanedo, G., Menendez Solana, G., Fernandez Divar, J. A., Galindo Rubin, P., & Alfonso Fernandez, A. (2021). Hip Chondral Defects: Arthroscopic Treatment With the Needle and Curette Technique and ChondroFiller. Arthroscopy Techniques, 10(6), e1369–e1376. https://doi.org/10.1016/j.eats.2021.03.011

Frequently Asked Questions

  • ChondroFiller is less invasive than traditional surgery, using small incisions and a liquid collagen scaffold. At MSK Doctors, Professor Paul Lee’s expertise ensures this scientifically advanced approach is delivered safely, offering patients quicker recovery and greater comfort when managing cartilage injuries.
  • Professor Paul Lee is a recognised cartilage expert and Royal College of Surgeons Ambassador. His extensive knowledge supports MSK Doctors’ use of evidence-based, minimally invasive treatments such as ChondroFiller, ensuring patients receive the latest orthopaedic advancements and highly personalised care.
  • Minimally invasive techniques like ChondroFiller result in smaller incisions, less pain, and reduced tissue damage. This means lower infection risk, quicker return to daily activities, and smaller scars. MSK Doctors, led by Professor Lee, emphasise patient comfort and best clinical outcomes.
  • Unlike traditional open surgeries, ChondroFiller uses keyhole incisions and injectable collagen matrix for repair. This technique, expertly performed at MSK Doctors by Professor Lee, delivers biological repair with minimal disruption, faster recovery, and innovative, precision-guided results tailored to each patient’s needs.
  • MSK Doctors blends innovation with rigorous clinical governance, led by Professor Paul Lee’s renowned expertise. Patients benefit from thorough assessments, minimally invasive treatments, and supportive aftercare. The team’s focus is on advanced options like ChondroFiller for safer, evidence-driven, and highly individualised care.

Legal & Medical Disclaimer

This article is written by an independent contributor and reflects their own views and experience, not necessarily those of Liquid Cartilage. It is provided for general information and education only and does not constitute medical advice, diagnosis, or treatment.

Always seek personalised advice from a qualified healthcare professional before making decisions about your health. Liquid Cartilage accepts no responsibility for errors, omissions, third-party content, or any loss, damage, or injury arising from reliance on this material.

If you believe this article contains inaccurate or infringing content, please contact us at [email protected].

Last reviewed: 2026For urgent medical concerns, contact your local emergency services.
Patient recovering with guidance

Take the Next Step

Cartilage damage won’t reverse on its own—yet with the right plan it can beprotected, repaired, and regenerated.

At Liquid Cartilage, you access world-leading science and a joint-preservation vision on Harley Street.

  • Start with a Discovery Call.
  • Or book your Consultation with Prof. Lee today.

(Consultation fee credited towards treatment if you proceed.)

Verified by DoctifyVerified by Doctify

Latest Blog

View all →
What the German gel injection actually does
25 Jul 2026

What the German gel injection actually does

ChondroFiller regenerates cartilage by recruiting the patient's own repair cells into a collagen scaffold that degrades as new tissue forms—unlike hyaluronic acid or Arthrosamid, which lubricate or cushion rather than rebuild.

Where to Get a ChondroFiller Injection in the UK
25 Jul 2026

Where to Get a ChondroFiller Injection in the UK

ChondroFiller injection works through matrix-induced chondrogenesis: the collagen scaffold self-gels in focal cartilage defects and stimulates progenitor cells to rebuild cartilage over weeks, though diffuse joint degradation does not respond. Available exclusively at the London Cartilage Clinic in the UK, the treatment is entirely private.

When Knee OCD Warrants a Cartilage Specialist
25 Jul 2026

When Knee OCD Warrants a Cartilage Specialist

Subchondral bone beneath the cartilage loses blood supply in osteochondritis dissecans and separates from surrounding tissue. Skeletal maturity — whether growth plates have closed — determines whether conservative treatment heals the lesion or surgery is necessary; symptom severity does not.

ChondroFiller injection for thumb basal joint arthritis
24 Jul 2026

ChondroFiller injection for thumb basal joint arthritis

ChondroFiller injection — a liquid collagen scaffold that recruits the patient's own progenitor cells to regenerate cartilage — produced joint-space widening and reduced bone marrow oedema on MRI in early and advanced thumb basal arthritis, alongside improved grip strength and pain relief in a six-month study.

Cartilage defect size and treatment on the medial femoral condyle
24 Jul 2026

Cartilage defect size and treatment on the medial femoral condyle

Articular cartilage cannot self-repair — it carries no blood supply and contains too few cells for regenerative response — so surgeons size cartilage defects on the medial femoral condyle in square centimetres to guide treatment: lesions under 1 cm² typically receive conservative care, 1–3 cm² warrant mosaicplasty or microfracture, and those exceeding 3 cm² require cell-based implantation.

ChondroFiller injection for chondromalacia patella
24 Jul 2026

ChondroFiller injection for chondromalacia patella

ChondroFiller injection places a collagen scaffold into a kneecap cartilage defect, gelling within minutes to trigger the body's own repair cells to build new tissue, with 70–85% of patients achieving symptom relief at three to five years.

Privacy & Cookies Policy